<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel>
<title>Semaglutide Scorecard news</title>
<link>https://semaglutide.igc2016.org/news</link>
<atom:link href="https://semaglutide.igc2016.org/news/rss.xml" rel="self" type="application/rss+xml"/>
<description>Weekly news on semaglutide and related medicines for South Africa.</description>
<language>en-za</language>
<item><title>Ozempic generic price in focus as semaglutide patents expire in India, Brazil and Canada</title><link>https://semaglutide.igc2016.org/news/ozempic-generic-price-what-patent-expiries-mean</link><guid isPermaLink="true">https://semaglutide.igc2016.org/news/ozempic-generic-price-what-patent-expiries-mean</guid><pubDate>Mon, 12 Oct 2026 08:00:00 GMT</pubDate><description>Ozempic generic price questions grow as semaglutide patents lapse in India, Brazil and Canada and Novo Nordisk signs new drug deals.</description></item>
<item><title>Ozempic shortage fears in South Africa as doctors warn on weight-loss use and cost</title><link>https://semaglutide.igc2016.org/news/ozempic-shortage-south-africa-fears-and-costs</link><guid isPermaLink="true">https://semaglutide.igc2016.org/news/ozempic-shortage-south-africa-fears-and-costs</guid><pubDate>Fri, 09 Oct 2026 08:00:00 GMT</pubDate><description>Ozempic shortage fears in South Africa: doctors warn about weight-loss use and cost, as a crackdown hits compounded GLP-1 injections.</description></item>
</channel></rss>
